Case report: Nutrition therapy and side-effects monitoring in critically ill coronavirus disease 2019 patients
In December 2019, a cluster of cases of pneumonia of unknown pathogen was identified in Wuhan, Hubei, China1. The pathogen was quickly revealed as a novel betacoronavirus named as severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2), and the pneumonia was named as coronavirus disease 2019 (COVID-19) by World Health Organization (WHO)2. WHO declared the outbreak of the disease as a public health emergency of international concern (PHEIC) on 30 January 20202. COVID-19 is highly contagious and has rapidly spread to the world, affecting more than 180 countries and over 15,000,000 people3.
Source: Heart and Lung - Category: Intensive Care Authors: Hanxiao Chen, Yu Xue, He Yu, Hong Chen, Yang Li, Yi Chen, Yuwei Zhang Source Type: research
More News: Cardiology | Coronavirus | COVID-19 | Emergency Medicine | Heart | Intensive Care | International Medicine & Public Health | Nutrition | Outbreaks | Pneumonia | Respiratory Medicine | SARS | WHO